Literature DB >> 19424745

Thymoma with dissemination: efficacy of macroscopic total resection of disseminated nodules.

Motoki Yano1, Hidefumi Sasaki, Haruhiro Yukiue, Osamu Kawano, Katsuhiro Okuda, Yu Hikosaka, Yoshitaka Fujii.   

Abstract

BACKGROUND: Advanced thymomas with disseminated nodules are difficult to manage, and the treatment strategy remains undefined.
METHODS: A total of 28 thymoma patients with pleural and/or pericardial disseminated nodules were treated at Nagoya City University Hospital. Among them, 21 patients underwent resection of thymoma and pleural disseminated nodules. These patients were reviewed in the present study.
RESULTS: Preoperative steroid pulse therapy was performed in 14 patients. Macroscopic total resection of all tumors was achieved in 15 patients. Postoperative adjuvant radiotherapy was performed for the mediastinum in 20 patients and hemithoracic irradiation (HTR) in 11 patients. The overall survival rate of operated 21 patients was 73.1% at 5 years. The patients who underwent resection showed a better prognosis than the patients without resection (p = 0.0006). Relapse was diagnosed in 14 of 21 patients who underwent resection. Disease-free survival was 67.5% at 1 year, 39.8% at 3 years, and 13.3% at 5 years. HTR alone did not improve the disease-free survival. Among the patients who underwent total resection, relapse-free survival was better than in the patients with subtotal resection (p = 0.009). Achievement of a trimodality therapy with preoperative steroid pulse, total resection, and postoperative HTR was associated with prolonged relapse-free survival in the operated patients (p = 0.027, hazard ratio 6.452).
CONCLUSIONS: Pursuing total resection for thymoma and disseminated nodules may be beneficial for stage IV thymoma. The combination of preoperative steroid pulse therapy, macroscopic total resection, and postoperative HTR may prolong the interval to relapse, but it did not lead to cure.

Entities:  

Mesh:

Year:  2009        PMID: 19424745     DOI: 10.1007/s00268-009-0069-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  17 in total

1.  Histopathologic changes of thymoma preoperatively treated with corticosteroids.

Authors:  H Tateyama; E Takahashi; Y Saito; I Fukai; Y Fujii; H Niwa; T Eimoto
Journal:  Virchows Arch       Date:  2001-03       Impact factor: 4.064

2.  Pleuropneumonectomy for the treatment of Masaoka stage IVA thymoma.

Authors:  Cameron D Wright
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

3.  Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up.

Authors:  Marco Lucchi; Franca Melfi; Paolo Dini; Fulvio Basolo; Andrea Viti; Francesco Givigliano; Carlo Alberto Angeletti; Alfredo Mussi
Journal:  J Thorac Oncol       Date:  2006-05       Impact factor: 15.609

4.  Chemotherapy for invasive thymoma. A 13-year experience.

Authors:  A Fornasiero; O Daniele; C Ghiotto; M Piazza; L Fiore-Donati; F Calabró; F Rea; M V Fiorentino
Journal:  Cancer       Date:  1991-07-01       Impact factor: 6.860

5.  Advanced stage thymomas and thymic carcinomas: results of multimodality treatments.

Authors:  Marco Lucchi; Marcello Carlo Ambrogi; Leonardo Duranti; Fulvio Basolo; Gabriella Fontanini; Carlo Alberto Angeletti; Alfredo Mussi
Journal:  Ann Thorac Surg       Date:  2005-06       Impact factor: 4.330

6.  Adjuvant radiotherapy for thymic epithelial tumor: treatment results and prognostic factors.

Authors:  Yulia Kundel; Alon Yellin; Aron Popovtzer; Raphael Pfeffer; Zvi Symon; David A Simansky; Bernice Oberman; Siegal Sadezki; Baruch Brenner; Raphael Catane; Mark L Levitt
Journal:  Am J Clin Oncol       Date:  2007-08       Impact factor: 2.339

Review 7.  Radiation therapy in the management of thymic tumors.

Authors:  Tony Y Eng; Charles R Thomas
Journal:  Semin Thorac Cardiovasc Surg       Date:  2005

8.  Thymoma: a clinicopathologic study based on the new World Health Organization classification.

Authors:  Kazuo Nakagawa; Hisao Asamura; Yoshihiro Matsuno; Kenji Suzuki; Haruhiko Kondo; Arafumi Maeshima; Etsuo Miyaoka; Ryosuke Tsuchiya
Journal:  J Thorac Cardiovasc Surg       Date:  2003-10       Impact factor: 5.209

9.  Feasibility of multimodality therapy including extended resections in stage IVA thymoma.

Authors:  James Huang; Nabil P Rizk; William D Travis; Venkatraman E Seshan; Manjit S Bains; Joseph Dycoco; Robert J Downey; Raja M Flores; Bernard J Park; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2007-10-26       Impact factor: 5.209

10.  Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan.

Authors:  Kazuya Kondo; Yasumasa Monden
Journal:  Ann Thorac Surg       Date:  2003-09       Impact factor: 4.330

View more
  11 in total

1.  Contemporary treatment for thymic malignancies: what's the bottom line?

Authors:  Byron D Hughes; Safa Maharsi; Ikenna C Okereke
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 2.  Thymoma and thymic carcinoma.

Authors:  Federico Venuta; Erino A Rendina; Marco Anile; Tiziano de Giacomo; Domenico Vitolo; Giorgio F Coloni
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-01-13

3.  Thymic neoplasm: a rare disease with a complex clinical presentation.

Authors:  Omar M Rashid; Anthony D Cassano; Kazuaki Takabe
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

4.  Entire hemithorax irradiation for Masaoka stage IVa thymomas.

Authors:  André Soares; Luís Vasco Louro; Marta Almeida; Olga Sousa
Journal:  Rep Pract Oncol Radiother       Date:  2012-07-15

5.  Is Hyperthermic Intrathoracic Chemotherapy (HITHOC) Safe and Efficacious in Masaoka-Koga Stage-IVA Thymoma? A Pilot Study.

Authors:  Arvind Kumar; Mohan Venkatesh Pulle; Belal Bin Asaf; Harsh Vardhan Puri; Aparna Kumar; Sukhram Bishnoi
Journal:  Indian J Surg Oncol       Date:  2021-09-07

Review 6.  Surgical Approaches for Stage IVA Thymic Epithelial Tumors.

Authors:  Mark Shapiro; Robert J Korst
Journal:  Front Oncol       Date:  2014-01-14       Impact factor: 6.244

7.  Thymectomy during Myasthenic Crisis under Artificial Respiration.

Authors:  Takuya Onuki; Sho Ueda; Shinichi Otsu; Takahiro Yanagihara; Naoki Kawakami; Masatoshi Yamaoka; Masaharu Inagaki
Journal:  Ann Thorac Cardiovasc Surg       Date:  2018-03-07       Impact factor: 1.520

8.  Optimal management of thymic malignancies: current perspectives.

Authors:  Gabrielle Drevet; Stéphane Collaud; François Tronc; Nicolas Girard; Jean-Michel Maury
Journal:  Cancer Manag Res       Date:  2019-07-22       Impact factor: 3.989

9.  Local radiotherapy for pleural dissemination of thymic tumors after initial treatment.

Authors:  Dai Okazaki; Yuta Shibamoto; Takeshi Yanagi; Satoshi Ishikura; Takuhito Kondo; Yuki Yamada; Masanari Niwa
Journal:  J Radiat Res       Date:  2021-07-10       Impact factor: 2.724

Review 10.  Treatment options for stage IVA thymic malignancies.

Authors:  Nicolas Girard
Journal:  Mediastinum       Date:  2019-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.